Neuranix

📍 Naples, Italy🗓 Founded 2017👥 17 employees💰 Last funded May 2023
NEURANIX, Transforming audiology diagnostics Neuranix is classified as an innovative company that develops and produces medical devices for people and pets. Through the acquisition of a new patented technology and thanks to the collaboration with specialists in the sector, we are able to develop solutions and specific applications in the audiological field, able to respond to the needs of humans and domestic companion animals. Research projects are carried out in collaboration with CNR (Italy’s National Research Institute), with important universities and specialist veterinary structures. Today Neuranix owns three patents in the audiological field. These patents are currently applied in two products; Vet-Wave and Med-Wave. The first, developed for the veterinary world, is already being commercialized, while the second, for human use, will be launched mid 2023. For more info please contact info@neuranix.com.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2017
Founded
Investor geography1 country
Italy
2
Frequently asked questions
Who invested in Neuranix?
Neuranix has 2 investors on record on gritt.io and 2 late-stage investors.
When did Neuranix last raise funding?
The most recent investment in Neuranix recorded on gritt.io was in May 2023.
When was Neuranix founded?
Neuranix was founded in 2017.
What industry is Neuranix in?
Neuranix operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Neuranix based?
Neuranix is headquartered in Naples, Italy.